📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial. (2014)

First Author: 3C Study Collaborative Group

Attributed to: CTSU resubmission: Proposal to increase capacity for methodological improvements in clinical trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(14)61095-3

PubMed Identifier: 25078310

Publication URI: http://europepmc.org/abstract/MED/25078310

Type: Journal Article/Review

Volume: 384

Parent Publication: Lancet (London, England)

Issue: 9955

ISSN: 0140-6736